Literature DB >> 10862532

Enhanced cardiovascular hemodynamics in endurance-trained postmenopausal women athletes.

S D McCole1, M D Brown, G E Moore, J M Zmuda, J D Cwynar, J M Hagberg.   

Abstract

PURPOSE: We sought to determine whether older women athletes who had habitually performed vigorous endurance exercise training had higher stroke volumes and cardiac outputs than sedentary postmenopausal women during maximal exercise.
METHODS: Seventeen endurance-trained, postmenopausal women athletes (age 65 +/- 4 yr; VO2max 2.11 +/- 0.31 L x min(-1), 38.3 mL x kg(-1) x min(-1)) and 14 sedentary, postmenopausal women (age 63 +/- 5 yr; VO2max 1.41 +/- 0.22 L x min(-1), 23.7 +/- 3.5 mL x kg(-1) x min(-1)) performed maximal treadmill exercise while cardiac output (via acetylene rebreathing) and other cardiovascular hemodynamics were measured. Approximately half of the subjects in each group were on hormone replacement therapy (HRT).
RESULTS: The greater VO2max of the athletes was the result of a greater cardiac output (12.8 +/- 1.6 vs. 9.3 +/- 1.4 L x min(-1)) resulting from their significantly larger stroke volume (80 +/- 10 vs 57 +/- 10 mL) at maximal exercise. There were no significant differences in maximal cardiac output or maximal stroke volume related to HRT status in the sedentary women or athletes.
CONCLUSIONS: These data indicate that endurance-trained, competitive, postmenopausal women have higher stroke volumes and cardiac outputs during maximal exercise, than their sedentary peers. However, these data suggest that HRT may not affect maximal CV function in sedentary or endurance-trained postmenopausal women.

Entities:  

Mesh:

Year:  2000        PMID: 10862532     DOI: 10.1097/00005768-200006000-00006

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  8 in total

Review 1.  Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism.

Authors:  W M Kohrt; R E Van Pelt; W S Gozansky
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Heart rate variability in athletes.

Authors:  André E Aubert; Bert Seps; Frank Beckers
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  The effect of lifelong exercise dose on cardiovascular function during exercise.

Authors:  Graeme Carrick-Ranson; Jeffrey L Hastings; Paul S Bhella; Naoki Fujimoto; Shigeki Shibata; M Dean Palmer; Kara Boyd; Sheryl Livingston; Erika Dijk; Benjamin D Levine
Journal:  J Appl Physiol (1985)       Date:  2014-01-23

4.  What future for older women ex-athletes?

Authors:  Anthea Tinker; Elodie Haines; Laura Molloy; Laura Pennells; Evelina Russell; Imogen Monks
Journal:  J R Soc Med       Date:  2017-03-02       Impact factor: 5.344

5.  The effect of lifelong endurance exercise on cardiovascular structure and exercise function in women.

Authors:  Graeme Carrick-Ranson; Nikita M Sloane; Erin J Howden; Paul S Bhella; Satyam Sarma; Shigeki Shibata; Naoki Fujimoto; Jeffrey L Hastings; Benjamin D Levine
Journal:  J Physiol       Date:  2020-05-21       Impact factor: 5.182

6.  Higher Cardiorespiratory Fitness in Older Trained Women is Due to Preserved Stroke Volume.

Authors:  Shilpa Dogra; Matthew D Spencer; Donald H Paterson
Journal:  J Sports Sci Med       Date:  2012-12-01       Impact factor: 2.988

7.  Studying the Effect of Garlic Consumption and Endurance Training on Serum Levels of Some Pro-and Anti-inflammatory Cytokines in Female Mice with Breast Cancer - A Randomized Trial.

Authors:  Mansour Enayatjazi; Fahimeh Esfarjani; Jalil Reisi; Seyed Jamal Moshtaghian
Journal:  Int J Prev Med       Date:  2022-03-12

8.  Daily Resting Heart Rate Variability in Adolescent Swimmers during 11 Weeks of Training.

Authors:  Sigitas Kamandulis; Antanas Juodsnukis; Jurate Stanislovaitiene; Ilona Judita Zuoziene; Andrius Bogdelis; Mantas Mickevicius; Nerijus Eimantas; Audrius Snieckus; Bjørn Harald Olstad; Tomas Venckunas
Journal:  Int J Environ Res Public Health       Date:  2020-03-22       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.